Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Proceeds from Lines of Credit

1.5 / 5 stars · 30/102 Roast Me

ACCURAY INCORPORATED Proceeds from Lines of Credit

ACCURAY INCORPORATED (ARAY) reported Proceeds from Lines of Credit of $12.00 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2026-05-06

  • ACCURAY INCORPORATED proceeds from lines of credit for the quarter ending 2026-03-31 was $5.00M.
  • ACCURAY INCORPORATED proceeds from lines of credit for the quarter ending 2025-12-31 was $5.00M, a 70.59% decline year-over-year.
  • ACCURAY INCORPORATED proceeds from lines of credit for the quarter ending 2025-09-30 was $2.00M, a 80.00% decline year-over-year.
  • ACCURAY INCORPORATED proceeds from lines of credit for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • ACCURAY INCORPORATED proceeds from lines of credit for fiscal 2025 was $27.00M, a 440.00% increase from fiscal 2024.
  • ACCURAY INCORPORATED proceeds from lines of credit for fiscal 2024 was $5.00M, a 0.00% change from fiscal 2023.
  • ACCURAY INCORPORATED proceeds from lines of credit for fiscal 2023 was $5.00M.
  • ACCURAY INCORPORATED proceeds from lines of credit for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2026-03-31$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$10.00M
derived: sum of 2 quarters · filed 2026-05-06
$12.00M
10-Q · filed 2026-05-06
$12.00M
derived: sum of 4 quarters · filed 2026-05-06
2025-12-31$5.00M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$7.00M
10-Q · filed 2026-02-17
$7.00M
derived: sum of 3 quarters · filed 2026-02-17
$7.00M
derived: sum of 4 quarters · filed 2026-05-06
2025-09-30$2.00M
10-Q/A · filed 2026-02-17
$2.00M
derived: sum of 2 quarters · filed 2026-02-17
$2.00M
derived: sum of 3 quarters · filed 2026-05-06
$19.00M
derived: sum of 4 quarters · filed 2026-05-06
2025-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-28
$0.00
derived: sum of 2 quarters · filed 2026-05-06
$17.00M
derived: sum of 3 quarters · filed 2026-05-06
$27.00M
10-K · filed 2025-08-28
2025-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$17.00M
derived: sum of 2 quarters · filed 2026-05-06
$27.00M
10-Q · filed 2026-05-06
$32.00M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$17.00M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$27.00M
10-Q · filed 2026-02-17
$32.00M
derived: sum of 3 quarters · filed 2026-02-17
$32.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-09-30$10.00M
10-Q/A · filed 2026-02-17
$15.00M
derived: sum of 2 quarters · filed 2026-02-17
$15.00M
derived: sum of 3 quarters · filed 2026-02-17
$15.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-28
$5.00M
derived: sum of 2 quarters · filed 2025-08-28
$5.00M
derived: sum of 3 quarters · filed 2025-08-28
$5.00M
10-K · filed 2025-08-28
2024-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02
$0.00
derived: sum of 2 quarters · filed 2025-05-02
$0.00
10-Q · filed 2025-05-02
$0.00
derived: sum of 4 quarters · filed 2025-05-02
2023-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-05
$0.00
10-Q · filed 2025-02-05
$0.00
derived: sum of 3 quarters · filed 2025-02-05
$0.00
derived: sum of 4 quarters · filed 2025-02-05
2023-09-30$0.00
10-Q · filed 2024-11-06
$0.00
derived: sum of 2 quarters · filed 2024-11-06
$0.00
derived: sum of 3 quarters · filed 2024-11-06
2023-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19
$0.00
derived: sum of 2 quarters · filed 2024-09-19
$5.00M
10-K · filed 2024-09-19
2023-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08
$5.00M
10-Q · filed 2024-05-08
2022-12-31$5.00M
10-Q · filed 2024-02-07
2022-06-30$0.00
10-K · filed 2024-09-19
2021-06-30$25.00M
10-K · filed 2023-09-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10